Tuberculosis
(TB) was a leading cause of death in the first half of the
century in Singapore. With improved socio-economic
conditions and established TB control measures, the
incidence rate of TB has declined from 307 cases per 100,000
population in 1960 to 47 per 100,000 in 2000. The number of
deaths from TB has also declined from 646 in 1960 to 97 in
2000.
Singapore has
a comprehensive TB Control Programme, which includes early
detection of TB cases, treatment of infectious TB cases,
treatment of infected contacts and prevention through BCG
vaccination. The TB Control Programme was further
strengthened in April 1997 with the implementation of the
Singapore TB Elimination Programme (STEP). With STEP, there
has been a 15% decline in the incidence of TB between 1997
and 2000.
BCG
vaccination is one of the strategies in the national TB
Control Programme. Since 1957, BCG vaccination has been
given to all newborns. In addition, a second BCG vaccination
has been given to children at 12 years or 16 years depending
on their reaction to the Mantoux skin test.
BCG
vaccination at birth has been shown to be highly effective
in preventing the serious forms of childhood TB such as TB
meningitis and disseminated TB. However, despite numerous
studies done worldwide over the years, there is no
scientific evidence to show that repeated BCG vaccination is
effective in protecting against TB. Based on the absence of
evidence to support the effectiveness of repeated BCG
vaccination, the World Health Organisation (WHO) no longer
recommends repeated BCG vaccination.
Repeated BCG
vaccination is not practised in many developed countries
including Australia, United Kingdom and the United States of
America. Hong Kong, which has an incidence of TB that is
about five times that of Singapore’s, discontinued the
practice of repeated BCG vaccination last year.
The Ministry
of Health, together with the Ministry’s expert advisory
committees, namely the International Advisory Panel to the
STEP, the STEP Committee and the Expert Committee on
Immunisation, have carefully reviewed the practice of a
second BCG vaccination and have decided to discontinue the
practice of a second BCG vaccination from 1 July 2001.
However, all newborns will continue to receive BCG
vaccination at birth. The Ministry has informed schools,
parents and doctors of the decision to discontinue the
practice of a second BCG vaccination.
The Ministry
reassures all parents that discontinuing the practice of a
second BCG vaccination does not pose a threat to the health
of their children. The Ministry will continue its efforts to
eliminate TB in Singapore.